STOCK TITAN

CloudMD Software & Services Inc - DOCRF STOCK NEWS

Welcome to our dedicated news page for CloudMD Software & Services (Ticker: DOCRF), a resource for investors and traders seeking the latest updates and insights on CloudMD Software & Services.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CloudMD Software & Services's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CloudMD Software & Services's position in the market.

Rhea-AI Summary
CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) shared an update on the success of its initiatives to grow the Company’s share of wallet among large global organizations and drive down costs by creating operational efficiencies. Key client successes include an additional 100,000 lives covered via new client signings for CloudMD portfolio solutions, with almost 50% of new clients in Q3 launching with more than one service. Major operational efficiency initiatives include the consolidation of internal cloud technology infrastructure into a singular tenant, expected to result in significant annual cost savings and reduced management overhead.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
CloudMD Software & Services Inc. invites investors to join their investor day webinar on October 5th at 10:00 am EDT.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
conferences
-
Rhea-AI Summary
CloudMD reported an adjusted EBITDA loss of $0.7 million, marking a $2.5 million improvement YoY. Gross margin increased by 510 bps over the comparable period in 2022. The company signed a significant contract for remote patient monitoring with a major U.S. Regional Hospital System, with meaningful revenue contribution expected in Q4. Q2 2023 revenue was $23.2 million, with a 7% YoY organic growth in Health and Wellness Services. The company expects low double-digit revenue growth in 2023 and aims for Adjusted EBITDA breakeven in Q4 2023. Cash balance was $18.8 million as of June 30, 2023. The company has completed its goal of operationalizing historical acquisitions and is focused on cross-selling and winning new customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
Rhea-AI Summary
CloudMD signs contract for Remote Patient Monitoring with major U.S. Hospital System
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.21%
Tags
none
-
Rhea-AI Summary
CloudMD Software & Services Inc. will release its financial results for Q2 2023 on August 28, 2023. The earnings conference call and webinar will be held on the same day at 9:30 am ET. The Company has focused on profitability and long-term growth, and will hold an Investor Day Call and Webinar on October 5, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.19%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
conferences earnings
CloudMD Software & Services Inc

OTC:DOCRF

DOCRF Rankings

DOCRF Stock Data

19.19M
304.25M
0.14%
0.47%
General Medical and Surgical Hospitals
Health Care and Social Assistance
Link
Canada
Vancouver